CIBLAGE DES MICROARN MIR-409-5P, MIR-379 ET MIR-154* POUR TRAITER LA MÉTASTASE OSSEUSE DU CANCER DE LA PROSTATE ET LE CANCER DU POUMON RÉSISTANT AUX MÉDICAMENTS
The present invention describes methods of treating cancer, cancer metastasis, and drug resistant cancers using miRNA inhibitors; for example, inhibitors of miR-409-5p. Also described are methods of using the miRNA as biomarkers; for example, to predict responsiveness to a cancer drug, to detect a disease state of cancer.